US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
WO2000013666A1
(en)
*
|
1998-09-05 |
2000-03-16 |
Seung Jin Lee |
Biodegradable particulate polymeric preparation and process for producing thereof
|
KR20000022894A
(ko)
*
|
1998-09-05 |
2000-04-25 |
이승진 |
생분해성 고분자 미립자형 제제 및 그 제조방법
|
DE19848849A1
(de)
*
|
1998-10-22 |
2000-04-27 |
Knoll Ag |
Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz
|
JP2002534371A
(ja)
*
|
1999-01-06 |
2002-10-15 |
コリア リサーチ インスティテュート オブ ケミカル テクノロジー |
水不溶性薬物を含む医薬的活性成分の製造方法及びそれを含む経口投与用医薬組成物
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
KR100372751B1
(ko)
*
|
1999-11-16 |
2003-02-17 |
한국과학기술원 |
생체조직공학용 다공성 생분해성 고분자 지지체의 제조방법
|
WO2000059476A1
(en)
|
1999-04-05 |
2000-10-12 |
Pharmaceutical Discovery Corporation |
Methods for fine powder formation
|
DE60003803T2
(de)
|
1999-04-16 |
2004-06-03 |
Novo Nordisk A/S |
Trockene formbare arzneistoffformulierung
|
CA2370781A1
(en)
*
|
1999-04-30 |
2000-11-09 |
Joseph P. Vacanti |
Fabrication of vascularized tissue using microfabricated two-dimensional molds
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
EP1183010A2
(en)
*
|
1999-06-04 |
2002-03-06 |
ALZA Corporation |
Implantable gel compositions and method of manufacture
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
US6822086B1
(en)
*
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
US8106098B2
(en)
*
|
1999-08-09 |
2012-01-31 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
WO2001010416A1
(en)
*
|
1999-08-11 |
2001-02-15 |
Alkermes Controlled Therapeutics, Inc. |
Method of delivering a chemotherapeutic agent to a solid tumor
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
AU1226901A
(en)
*
|
1999-10-22 |
2001-05-08 |
Amgen, Inc. |
Biodegradable microparticles with novel erythropoietin stimulating protein
|
WO2001047572A2
(en)
*
|
1999-12-29 |
2001-07-05 |
Advanced Cardiovascular Systems, Inc. |
Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
|
US7029700B2
(en)
*
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
AU2001231000A1
(en)
|
2000-01-19 |
2001-07-31 |
Pharmaceutical Discovery Corporation |
Dry powder formulations of antihistamine for nasal administration
|
AU2001252890B2
(en)
*
|
2000-03-02 |
2005-06-02 |
Microchips, Inc. |
Microfabricated devices for the storage and selective exposure of chemicals and devices
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
EP1272231A1
(en)
|
2000-04-06 |
2003-01-08 |
University Technology Corporation |
Compositions and methods for promoting wound healing
|
US7776021B2
(en)
*
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
WO2002005744A1
(en)
*
|
2000-07-14 |
2002-01-24 |
Novo Nordisk A/S |
Method of moulding a pharmaceutical composition in a packaging material
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
ATE449596T1
(de)
*
|
2000-08-15 |
2009-12-15 |
Univ Illinois |
Verfahren zur herstellung von mikropartikeln
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
CA2420854C
(en)
*
|
2000-09-01 |
2013-07-30 |
Palmaya Pty Ltd |
Slow release pharmaceutical preparation and method of administering of same
|
US7666445B2
(en)
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
AU2002239410B2
(en)
|
2000-10-31 |
2008-05-01 |
Eisai Inc. |
CYP1B1 nucleic acids and methods of use
|
WO2002053193A2
(en)
|
2001-01-02 |
2002-07-11 |
The Charles Stark Draper Laboratory, Inc. |
Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
|
CA2438208A1
(en)
*
|
2001-02-07 |
2002-08-15 |
Durect Corporation |
Devices and methods for management of bone density
|
WO2002094226A1
(de)
*
|
2001-05-23 |
2002-11-28 |
Hexal Ag |
Homogenisat für implantate und mikropartikel
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
KR100840219B1
(ko)
*
|
2001-08-03 |
2008-06-23 |
도레이 가부시끼가이샤 |
수지 조성물 및 그것으로 이루어진 성형품, 필름 및 섬유
|
US7687053B2
(en)
|
2001-08-20 |
2010-03-30 |
Boston Scientific Scimed, Inc. |
Embolic compositions with non-cyanoacrylate rheology modifying agents
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
DE60323936D1
(de)
|
2002-01-14 |
2008-11-20 |
Gen Hospital Corp |
Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
|
JP2005530695A
(ja)
*
|
2002-02-15 |
2005-10-13 |
ザイコス インク. |
生理活性物質を細胞内に導入するエレクトロポレーション法
|
US8728510B1
(en)
|
2002-03-15 |
2014-05-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing a bioadhesive material
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
AU2003254023A1
(en)
*
|
2002-07-19 |
2004-02-09 |
The General Hospital Corporation |
Oxime conjugates and methods for their formation and use
|
GB2399084B
(en)
*
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
KR20050056222A
(ko)
*
|
2002-09-30 |
2005-06-14 |
아쿠스피어 인코포레이티드 |
흡입용 지속 방출형 다공성 미세입자
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
EP1589814B1
(en)
|
2003-01-16 |
2009-08-12 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
US7658998B2
(en)
*
|
2003-01-22 |
2010-02-09 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
DE10303584A1
(de)
*
|
2003-01-30 |
2004-08-12 |
Stauss, Robert, Dr. |
Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
US20070122487A1
(en)
*
|
2003-03-19 |
2007-05-31 |
University Of Kentucky Research Foundation |
(Poly(acryloyl-hydroxyethyl starch)-plga composition microspheres
|
US7051485B2
(en)
*
|
2003-04-29 |
2006-05-30 |
Greg Burnette |
Ceiling panel system
|
US7960166B2
(en)
|
2003-05-21 |
2011-06-14 |
The General Hospital Corporation |
Microfabricated compositions and processes for engineering tissues containing multiple cell types
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
CA2537993C
(en)
*
|
2003-09-05 |
2012-08-28 |
The General Hospital Corporation |
Dual phase drug release system
|
US20050181059A1
(en)
*
|
2003-09-30 |
2005-08-18 |
Spherics, Inc. |
Nanoparticulate therapeutic biologically active agents
|
JP2007533634A
(ja)
*
|
2003-09-30 |
2007-11-22 |
アキュスフィア, インコーポレイテッド |
注射、経口、または局所用の徐放性医薬製剤
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
EP2233150B1
(de)
*
|
2003-12-30 |
2016-09-07 |
Augustinus Bader |
Erythropoietin zur Anwendung bei der Behandlung von Wunden oder der Transplantation von Zellen
|
CA2553254C
(en)
*
|
2004-01-12 |
2013-12-17 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
WO2005072702A2
(en)
*
|
2004-01-20 |
2005-08-11 |
Alkermes Controlled Therapeutics, Inc. |
Method for milling frozen microparticles
|
US20050188921A1
(en)
*
|
2004-02-27 |
2005-09-01 |
Anthony Malone |
Matrix assisted pulsed-laser evaporation technique for coating a medical device and associated system and medical device
|
US7358246B2
(en)
*
|
2004-04-08 |
2008-04-15 |
Wyeth |
Thioamide derivatives as progesterone receptor modulators
|
AU2005237520B2
(en)
|
2004-04-27 |
2012-01-19 |
Wyeth |
Purification of progesterone receptor modulators
|
US8808746B2
(en)
*
|
2004-04-30 |
2014-08-19 |
Fresenius Kabi Usa, Llc |
Sustained-release microspheres and methods of making and using same
|
WO2006009801A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Valera Pharmaceuticals, Inc. |
Compositions and methods for treating central precocious puberty
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
AU2005325213B2
(en)
|
2004-08-04 |
2010-10-07 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
WO2006023849A2
(en)
|
2004-08-20 |
2006-03-02 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
JP4990142B2
(ja)
|
2004-08-23 |
2012-08-01 |
マンカインド コーポレイション |
薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
WO2006037080A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Uv cured gel and method of making
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US8312836B2
(en)
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
US8001922B2
(en)
|
2004-09-28 |
2011-08-23 |
Atrium Medical Corporation |
Application of a coating on a medical device
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
US8834901B2
(en)
*
|
2004-10-14 |
2014-09-16 |
Trustees Of Tufts College |
Electrochemically degradable polymers
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
WO2006078841A1
(en)
*
|
2005-01-21 |
2006-07-27 |
President And Fellows Of Harvard College |
Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
KR101399911B1
(ko)
*
|
2005-03-11 |
2014-06-19 |
엔도 파마슈티컬즈, 솔루션스 아이엔씨. |
옥트레오타이드의 방출 조절형 제형
|
IN2014DN09128A
(es)
|
2005-09-14 |
2015-07-10 |
Mannkind Corp |
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
US9278161B2
(en)
*
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
EP1933991A4
(en)
|
2005-10-15 |
2012-05-02 |
Atrium Medical Corp |
HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
BRPI0707991B8
(pt)
|
2006-02-22 |
2021-05-25 |
Mannkind Corp |
métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
|
WO2007109244A2
(en)
*
|
2006-03-21 |
2007-09-27 |
Morehouse School Of Medicine |
Novel nanoparticles for delivery of active agents
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
US20100285094A1
(en)
*
|
2006-04-20 |
2010-11-11 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
US20080075777A1
(en)
*
|
2006-07-31 |
2008-03-27 |
Kennedy Michael T |
Apparatus and methods for preparing solid particles
|
ITMI20061538A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
ITMI20061545A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
EP2626091B1
(en)
|
2006-11-06 |
2016-09-28 |
Atrium Medical Corporation |
Coated surgical mesh
|
CL2008000662A1
(es)
*
|
2007-03-09 |
2008-04-25 |
Wyeth Corp |
Forma cristalina de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il) tiazo-4-il) benzonitrilo; metodo para la preparacion de dicho compuesto; composicion farmaceutica que comprende a dicho compuesto; kit farmaceutico que comprende a dicho compuesto; y su uso
|
CA2685397C
(en)
*
|
2007-04-27 |
2016-07-26 |
Endo Pharmaceuticals Solutions Inc. |
Implant device release agents and methods of using same
|
EP2224913B1
(en)
|
2007-12-04 |
2014-10-15 |
Remedy Pharmaceuticals, Inc. |
Improved formulations and methods for lyophilization and lyophilates provided thereby
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
JP5774853B2
(ja)
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
TWI524904B
(zh)
*
|
2008-05-09 |
2016-03-11 |
歌林達股份有限公司 |
製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法
|
US20090325964A1
(en)
*
|
2008-05-23 |
2009-12-31 |
Wyeth |
Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP3281663B8
(en)
|
2008-06-13 |
2022-09-21 |
MannKind Corporation |
Breath powered dry powder inhaler for drug delivery
|
BRPI0914308B8
(pt)
|
2008-06-20 |
2021-06-22 |
Mannkind Corp |
sistema de inalação
|
AU2009262263B2
(en)
*
|
2008-06-25 |
2014-08-14 |
Endo Pharmaceuticals Solutions Inc. |
Octreotide implant having a release agent
|
WO2009158412A2
(en)
|
2008-06-25 |
2009-12-30 |
Endo Pharmaceuticals Solutions Inc. |
Sustained delivery of exenatide and other polypeptides
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
PE20100746A1
(es)
*
|
2008-12-10 |
2010-11-04 |
Mersana Therapeutics Inc |
Formulaciones farmaceuticas de conjugados de camptotecina-polimero biocompatibles y biodegradables
|
CN102281870B
(zh)
|
2008-12-10 |
2015-03-04 |
安徽中人科技有限责任公司 |
新型控释组合物
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
ES2644885T3
(es)
*
|
2009-01-23 |
2017-11-30 |
Evonik Corporation |
Procedimiento continuo por emulsión doble para fabricar micropartículas
|
WO2010105094A1
(en)
|
2009-03-11 |
2010-09-16 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
WO2010144789A2
(en)
|
2009-06-12 |
2010-12-16 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
CA2765971C
(en)
|
2009-07-22 |
2017-08-22 |
Gruenenthal Gmbh |
Hot-melt extruded controlled release dosage form
|
JP2012533586A
(ja)
*
|
2009-07-22 |
2012-12-27 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
酸化安定化された不正使用防止剤形
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
JP2013503166A
(ja)
*
|
2009-08-25 |
2013-01-31 |
カーディオカイン・バイオファーマ・エルエルシー |
不溶性剤を送達するための組成物
|
US20110091518A1
(en)
*
|
2009-09-22 |
2011-04-21 |
Danielle Biggs |
Implant devices having varying bioactive agent loading configurations
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
ES2606227T3
(es)
*
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
AU2011271097B2
(en)
|
2010-06-21 |
2014-11-27 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
EP2593141B1
(en)
|
2010-07-16 |
2018-07-04 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
AU2011297901B2
(en)
|
2010-09-02 |
2014-07-31 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
NZ608865A
(en)
|
2010-09-02 |
2015-03-27 |
Gruenenthal Chemie |
Tamper resistant dosage form comprising an anionic polymer
|
KR102007997B1
(ko)
|
2011-02-07 |
2019-08-07 |
라이프 테크놀로지스 코포레이션 |
감수성 화합물을 안정화시키는 조성물 및 방법
|
EP2694402B1
(en)
|
2011-04-01 |
2017-03-22 |
MannKind Corporation |
Blister package for pharmaceutical cartridges
|
WO2012172449A1
(en)
|
2011-06-13 |
2012-12-20 |
Pfizer Inc. |
Lactams as beta secretase inhibitors
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CN103841964A
(zh)
|
2011-07-29 |
2014-06-04 |
格吕伦塔尔有限公司 |
提供药物立即释放的抗破碎片剂
|
PT2736497T
(pt)
|
2011-07-29 |
2017-11-30 |
Gruenenthal Gmbh |
Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
|
JP2014521743A
(ja)
*
|
2011-08-15 |
2014-08-28 |
モアハウス スクール オブ メディスン |
ガン細胞を特異的に標的とするための送達システムおよびその使用方法
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
EP2790667B1
(en)
|
2011-12-16 |
2017-03-22 |
DSM IP Assets B.V. |
Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
|
JP6117249B2
(ja)
|
2012-02-28 |
2017-04-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
|
WO2013156453A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
WO2014012069A2
(en)
|
2012-07-12 |
2014-01-16 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
KR102499439B1
(ko)
|
2013-03-15 |
2023-02-13 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
CA2913209A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper resistant dosage form with bimodal release profile
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
CA2918369C
(en)
|
2013-07-18 |
2021-06-29 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
EP3073994A1
(en)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
EP3346991A1
(en)
|
2015-09-10 |
2018-07-18 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
WO2017077066A1
(en)
|
2015-11-06 |
2017-05-11 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same
|